A2: Pfizer

Columnist David Collins of The Day, a newspaper in New London, Connecticut, interviews Stephen Rapundalo for a look at Ann Arbor following Pfizer’s departure. Says Rapundalo, a former Pfizer researcher and current city council member: “We have developed a real strength here largely as the result of the downsizing of Pfizer. The skill set has stayed.” [Source]